You are about to leave this website for another external website. Gamida Cell has no responsibility for the content of such other sites and is not liable for any damages or injury arising from that content. Any links to other sites are provided merely as a convenience to the users of this website.
1504472779667619852
Allo-transplant is a potentially curative treatment option for patients with hematologic malignancies. Learn more about the potential omidubicel, our lead cell therapy candidate, holds for patients: https://t.co/5HaGv5VTqa https://t.co/HJVtsq0ZYC